Health Care
featured
Chuck Rosenberg, chief of the DEA, said that smoking marijuana should not be considered medical treatment on Wednesday, calling the notion a "joke."
» Read MoreMore
-
People who buy the least expensive health plans on the biggest Obamacare exchange without getting financial assistance will face big price increases.
-
Philidor, a pharmacy facing backlash from accusations about Valeant Pharmaceuticals' business model, announced it would close.
-
The head of the firm behind a scathing report that sparked scrutiny of Valeant said he wants to take himself out of the story.
-
An investigation was underway Saturday in an E. coli outbreak linked to Chipotle restaurants in Washington state and Oregon.
-
Many returning Obamacare customers will be able to find plans costing them less than $100, or even $75 per month.
-
The Cleveland Clinic will work to verify technology devised by diagnostic start-up Theranos.
-
Pressure from insurance company negotiations and higher drug costs are forcing hospitals to become more efficient, health-care chiefs said.
-
Valeant said it is terminating all ties with Philidor due to allegations relating to the specialty pharmacy distributor's business practices.
-
Data from Sikka Software show that dentists are the biggest winners during the Halloween season, because of so many cracked teeth from hard candy.
-
Health and nutrition guidelines should "cease recommending low-fat diets for weight loss," says a new meta-analysis from Harvard.
-
The field of gene testing is verging on a "huge breakthrough," Cleveland Clinic CEO Toby Cosgrove told CNBC.
-
The number of preferred provider organization health plans will fall sharply, by more than 40 percent.
-
Employment-related stress can cut the number of years people live, according to a study discussed in Washington Post's Wonkblog.
-
Are we about to lose our appetite for hot dogs, bacon, and pies?
-
Health-care expenses in retirement are climbing. Sharon Epperson shares tips on how to plan to make sure you're covered.
-
A possible deal between Ireland-based Allergan and U.S. drugmaker Pfizer raises questions about another pharmaceutical tax inversion.
-
With the proposed budget deal, about 17 million beneficiaries would see their Part B premiums rise 14 percent instead, USA TODAY reports.
-
The Chinese Communist Party's decision to do away with the one-child policy will benefit companies that sell baby products market in the country.
-
Pfizer has held early talks with Allergan to discuss what could be the biggest takeover deal this year, according to media reports.
-
Existing Obamacare customers who switched plans for 2015 saved an average of almost $400 per year in premiums.
Contact Health Care
-
CNBC NEWSLETTERS
Get the best of CNBC in your inbox
To learn more about how we use your information,
please read our Privacy Policy.▲-
Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.
-
Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.